Reliq Health Technologies Stock Gross Profit

RQHTF Stock  USD 0  0.0001  10.00%   
Reliq Health Technologies fundamentals help investors to digest information that contributes to Reliq Health's financial success or failures. It also enables traders to predict the movement of Reliq Pink Sheet. The fundamental analysis module provides a way to measure Reliq Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Reliq Health pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Reliq Health Technologies Company Gross Profit Analysis

Reliq Health's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Gross Profit

 = 

Revenue

-

Cost of Revenue

More About Gross Profit | All Equity Analysis

Current Reliq Health Gross Profit

    
  5.3 M  
Most of Reliq Health's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Reliq Health Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Competition

According to the company disclosure, Reliq Health Technologies reported 5.3 M of gross profit. This is 99.76% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The gross profit for all United States stocks is 99.98% higher than that of the company.

Reliq Gross Profit Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Reliq Health's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Reliq Health could also be used in its relative valuation, which is a method of valuing Reliq Health by comparing valuation metrics of similar companies.
Reliq Health is currently under evaluation in gross profit category among its peers.

Reliq Fundamentals

About Reliq Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Reliq Health Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reliq Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reliq Health Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Reliq Pink Sheet

Reliq Health financial ratios help investors to determine whether Reliq Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Reliq with respect to the benefits of owning Reliq Health security.